Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.08
-0.44 (-5.85%)
Apr 29, 2026, 10:03 AM EDT - Market open
Wave Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 544.59 | 602.07 | 302.08 | 200.35 | 88.5 | 150.56 | Upgrade
|
| Cash & Short-Term Investments | 544.59 | 602.07 | 302.08 | 200.35 | 88.5 | 150.56 | Upgrade
|
| Cash Growth | 124.04% | 99.31% | 50.77% | 126.39% | -41.22% | -18.39% | Upgrade
|
| Receivables | - | 1.28 | 1.42 | 21.09 | - | - | Upgrade
|
| Prepaid Expenses | 13.23 | 8.4 | 9.54 | 9.91 | 7.93 | 6.58 | Upgrade
|
| Other Current Assets | 3.46 | 3.08 | 7.35 | 4.02 | 2.11 | 5.42 | Upgrade
|
| Total Current Assets | 561.27 | 614.81 | 320.39 | 235.37 | 98.54 | 162.56 | Upgrade
|
| Property, Plant & Equipment | 18.07 | 19.86 | 28 | 35.72 | 44.13 | 40.64 | Upgrade
|
| Other Long-Term Assets | 4.2 | 3.82 | 3.82 | 3.86 | 3.72 | 3.8 | Upgrade
|
| Total Assets | 583.54 | 638.5 | 352.21 | 274.95 | 146.39 | 207.01 | Upgrade
|
| Accounts Payable | 19.06 | 15.7 | 16.26 | 12.84 | 16.92 | 7.28 | Upgrade
|
| Accrued Expenses | 13.04 | 26.56 | 21.08 | 16.83 | 17.55 | 14.86 | Upgrade
|
| Current Portion of Leases | 8.33 | 8.36 | 7.64 | 6.71 | 5.5 | 4.96 | Upgrade
|
| Current Unearned Revenue | 9.4 | 44.44 | 65.97 | 150.06 | 31.56 | 37.1 | Upgrade
|
| Total Current Liabilities | 49.83 | 95.07 | 110.95 | 186.44 | 71.52 | 64.2 | Upgrade
|
| Long-Term Leases | 7.39 | 9.41 | 17.77 | 25.4 | 32.12 | 24.96 | Upgrade
|
| Long-Term Unearned Revenue | 14.6 | 7.8 | 6.1 | 15.6 | 79.77 | 77.48 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.19 | - | Upgrade
|
| Total Liabilities | 71.81 | 112.27 | 134.82 | 227.45 | 183.6 | 166.64 | Upgrade
|
| Common Stock | 1,627 | 1,616 | 1,175 | 935.37 | 802.83 | 749.85 | Upgrade
|
| Additional Paid-In Capital | 237.43 | 228.37 | 156.45 | 129.24 | 119.44 | 87.98 | Upgrade
|
| Retained Earnings | -1,352 | -1,326 | -1,122 | -1,025 | -967.34 | -805.51 | Upgrade
|
| Comprehensive Income & Other | -0.25 | -0.25 | -0.26 | -0.12 | -0.03 | 0.18 | Upgrade
|
| Total Common Equity | 511.73 | 518.36 | 209.52 | 39.63 | -45.09 | 32.5 | Upgrade
|
| Shareholders' Equity | 511.73 | 526.23 | 217.39 | 47.5 | -37.22 | 40.37 | Upgrade
|
| Total Liabilities & Equity | 583.54 | 638.5 | 352.21 | 274.95 | 146.39 | 207.01 | Upgrade
|
| Total Debt | 15.72 | 17.77 | 25.4 | 32.12 | 37.61 | 29.92 | Upgrade
|
| Net Cash (Debt) | 528.88 | 584.3 | 276.67 | 168.23 | 50.88 | 120.65 | Upgrade
|
| Net Cash Growth | 140.97% | 111.19% | 64.46% | 230.63% | -57.83% | -22.26% | Upgrade
|
| Net Cash Per Share | 2.97 | 3.46 | 2.00 | 1.59 | 0.65 | 2.33 | Upgrade
|
| Filing Date Shares Outstanding | 192.38 | 188.25 | 153.49 | 122.28 | 98.1 | 60.84 | Upgrade
|
| Total Common Shares Outstanding | 192.34 | 187.66 | 153.04 | 119.16 | 86.92 | 59.84 | Upgrade
|
| Working Capital | 511.44 | 519.75 | 209.44 | 48.93 | 27.02 | 98.36 | Upgrade
|
| Book Value Per Share | 2.66 | 2.76 | 1.37 | 0.33 | -0.52 | 0.54 | Upgrade
|
| Tangible Book Value | 511.73 | 518.36 | 209.52 | 39.63 | -45.09 | 32.5 | Upgrade
|
| Tangible Book Value Per Share | 2.66 | 2.76 | 1.37 | 0.33 | -0.52 | 0.54 | Upgrade
|
| Machinery | - | 26.37 | 26.19 | 26.07 | 25.51 | 25.66 | Upgrade
|
| Construction In Progress | - | 0.6 | 0.35 | 0.29 | 0.32 | 0.03 | Upgrade
|
| Leasehold Improvements | - | 28.94 | 28.89 | 28.53 | 28.41 | 27.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.